🔥GASTRITIS: Dile ADIÓS con estos 5 REMEDIOS según ESPECIALISTA | #Diagnóstico 185 | Mr Doctor

Overview

The episode argues that “gastritis” is an overused and often poorly defined label. Many people who self-report “gastritis” may actually have different underlying conditions—such as functional dyspepsia, peptic ulcer disease, or reflux. The specialist emphasizes that the key is to clarify the type and cause of symptoms rather than treating everyone the same.

Key Medical Points

Peptic ulcer disease (acid-peptic disorders)

Peptic ulcer disease is presented as a group of conditions related to stomach acid acting on the stomach/duodenum when the protective mucosal barrier fails. Protective factors include:

• Mucus
• Blood flow
• Protective substances such as prostaglandins

Helicobacter pylori (H. pylori)

The episode highlights H. pylori as a major cause of acid-peptic problems and as a type 1 carcinogen linked to gastric cancer. It’s also associated with other malignancies and conditions, including:

• Mucosa-associated malignant lymphoma
• Thrombocytopenic purpura

Common infection vs. cancer risk

While H. pylori is extremely common (noted as up to ~70% in Latin America and ~50% globally), the host stresses that cancer is multifactorial—so not everyone infected will develop cancer.

Red flags requiring urgent evaluation

The episode lists warning signs for serious disease, including:

• Persistent or worsening pain
• Weight loss
• Early fullness
• Chronic nausea
• Gastrointestinal bleeding, such as:
  • Black stools
  • Vomiting blood
• Other symptoms that warrant prompt medical assessment and possible endoscopy

Diagnosis: Who Should Be Tested and How

Who needs testing

Not everyone needs testing. H. pylori testing is considered especially for:

• People with relevant symptoms
• Certain risk situations, such as first-degree relatives with cancer
• Other clinical indications

Diagnostic methods discussed

• Urea breath test
• Stool (fecal) antigen test
  • Highlighted for detecting active infection
  • Useful for monitoring treatment success
• Serology (antibodies)
  • Criticized because it may not distinguish past exposure from current active infection
• Endoscopy with biopsy
  • Presented as a “gold standard” in this context
  • Can include specialized testing (e.g., urease-based and other lab techniques)

Reinfection and ongoing risk

The episode warns about reinfection and ongoing risk due to infectious transmission routes, such as:

• Fecal-oral
• Vomit/oral contact
• Contaminated endoscopes This risk can be higher in settings with lower hygiene or overcrowding.

Treatment Approach

H. pylori treatment regimen

H. pylori treatment is described as:

• Two antibiotics plus an acid-suppressing medication
  • Acid suppression helps allow mucosal healing
• Typically for about 15 days
• Requires adherence and follow-up due to risk of treatment failure, including:
  • Antimicrobial resistance
  • Incomplete adherence
  • Side effects
  • Other practical barriers

Follow-up testing

After treatment, follow-up testing is emphasized—often using fecal antigen testing rather than repeating endoscopy, unless ulcers or other serious findings are present.

PPIs (proton pump inhibitors)

PPIs (e.g., omeprazole and related drugs) are explained as blocking acid secretion to allow healing. Key warning:

• Don’t self-medicate or take PPIs “just in case” without a plan.

Typical durations mentioned are:

• ~4–6 weeks on average
• With tapering/de-escalation based on diagnosis and response

NSAIDs and gastritis/bleeding risk

NSAIDs (e.g., ibuprofen) are singled out as a common cause of erosive/hemorrhagic gastritis and upper GI bleeding, particularly in:

• Elderly patients
• People at higher risk

The implication is to prescribe NSAIDs appropriately and consider stomach protection when needed.

Other therapies mentioned

• H2 blockers (e.g., famotidine) for maintenance/de-escalation in some cases
• Sucralfate
  • Particularly useful in erosive gastritis
  • Also relevant in some alkaline bile reflux scenarios
  • Needs an acidic environment to work effectively, so it should not be mixed improperly with acid suppression
• Symptom-relief agents (antacids/gel-like protectants)
  • Framed as complementary, not curative

Myths Addressed

• Spicy food
  • Claims that spice “causes gastritis” are rejected.
  • Spice may irritate more when there is already an injury/lesion, but it doesn’t explain widespread prevalence.
• Stress gastritis
  • Stress-related ulcer/gastritis can occur (especially in ICU “stress ulcer” contexts).
  • Stress can also worsen symptoms.
• Omeprazole long-term risks
  • The specialist notes possible risks with prolonged use (e.g., osteoporosis, pneumonia, dementia) but argues they are generally not common or decisive with appropriately indicated, time-limited therapy.
  • The solution is correct dose and duration, not stopping therapy entirely when needed.
• Functional medicine and unproven supplements
  • The guest warns against “functional medicine” branding by non-medically appropriate providers.
  • Warns against “natural” supplements marketed without evidence, including examples of possible adulteration/hidden steroids.
  • Advises against wasting money on ineffective or dangerous alternatives.

Cancer Prevention and Screening Guidance

Stomach cancer prevention

Prevention advice includes:

• Avoid smoking and reduce risk factors (diet quality emphasized)
• Mention of associations with obesity and nitrates/nitrosamines
  • Example cited: grilled/smoked meats and processed foods
• Emphasis on healthy dietary patterns and avoiding processed/fried foods

Screening guidance

The episode argues routine endoscopy for stomach cancer is not broadly required without symptoms, while emphasizing preventive evaluation when red flags exist.

It strongly emphasizes colon cancer screening in Mexico, highlighting:

• Colonoscopy as the gold standard
• Starting at ~45
• Earlier screening for family history or high-risk syndromes
• The importance of not delaying evaluation of rectal bleeding

Presenters / Contributors

• Octavio Rooy (Mr. Doctor) — host/presenter
• Dr. Pepe Bandera Quijano (Dr. Pepe Bandera) — internist, gastroenterologist, endoscopist, guest expert